Covid-19 roundup: So­ri­ot — vac­cine could be ready by year's end; WHO omits remde­sivir from de­vel­op­ing coun­tries plan

As­traZeneca’s Covid-19 vac­cine could be ready for large-scale dis­tri­b­u­tion by the end of this year, CEO Pas­cal So­ri­ot said in an in­ter­view Thurs­day morn­ing.

Speak­ing with Bloomberg, So­ri­ot said that de­spite the com­pa­ny’s Phase III tri­al be­ing de­layed ear­li­er this year, a resur­gence in Covid-19 cas­es has al­lowed re­searchers to gath­er the da­ta that they need. The British drug­mak­er is on track to re­port the late-stage re­sults by the end of 2020.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER